Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies

RH Advani, JJ Buggy, JP Sharman… - Journal of Clinical …, 2013 - ascopubs.org
Purpose Survival and progression of mature B-cell malignancies depend on signals from the
B-cell antigen receptor, and Bruton tyrosine kinase (BTK) is a critical signaling kinase in this …

Revisiting neutrophil gelatinase-associated lipocalin (NGAL) in cancer: saint or sinner?

B Bauvois, SA Susin - Cancers, 2018 - mdpi.com
Human neutrophil gelatinase-associated lipocalin (NGAL) is a glycoprotein present in a
wide variety of tissues and cell types. NGAL exists as a 25 kDa monomer, a 46 kDa …

The clinically active BTK inhibitor PCI-32765 targets B-cell receptor–and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia

MFM de Rooij, A Kuil, CR Geest… - Blood, The Journal …, 2012 - ashpublications.org
Small-molecule drugs that target the B-cell antigen receptor (BCR) signalosome show
clinical efficacy in the treatment of B-cell non-Hodgkin lymphoma. These agents, including …

Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia

Y Kikushige, F Ishikawa, T Miyamoto, T Shima, S Urata… - Cancer cell, 2011 - cell.com
We report here that in chronic lymphocytic leukemia (CLL), the propensity to generate clonal
B cells has been acquired already at the hematopoietic stem cell (HSC) stage. HSCs …

Bcl-2 interaction with the inositol 1, 4, 5-trisphosphate receptor: role in Ca2+ signaling and disease

CW Distelhorst, MD Bootman - Cell calcium, 2011 - Elsevier
The Bcl-2 protein, best known for its ability to inhibit apoptosis, interacts with the inositol 1, 4,
5-trisphosphate receptor (IP3R) Ca2+ channel to regulate IP3-mediated Ca2+ release from …

[HTML][HTML] The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia

D Brusa, S Serra, M Coscia, D Rossi, G D'Arena… - …, 2013 - ncbi.nlm.nih.gov
Chronic lymphocytic leukemia is marked by profound defects in T-cell function. Programmed
death-1 is a receptor involved in tumor-mediated immunosuppression through binding of the …

Nanowire-mediated delivery enables functional interrogation of primary immune cells: application to the analysis of chronic lymphocytic leukemia

AK Shalek, JT Gaublomme, L Wang, N Yosef… - Nano …, 2012 - ACS Publications
A circuit level understanding of immune cells and hematological cancers has been severely
impeded by a lack of techniques that enable intracellular perturbation without significantly …

Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia

XJ Yan, I Dozmorov, W Li… - Blood, The Journal …, 2011 - ashpublications.org
Individual cytokines and groups of cytokines that might represent networks in chronic
lymphocytic leukemia (CLL) were analyzed and their prognostic values determined. Serum …

TIGIT expressing CD4+ T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia

K Catakovic, FJ Gassner, C Ratswohl… - …, 2018 - Taylor & Francis
While research on T cell exhaustion in context of cancer particularly focuses on CD8+
cytotoxic T cells, the role of inhibitory receptors on CD4+ T-helper cells have remained …

LYN kinase in the tumor microenvironment is essential for the progression of chronic lymphocytic leukemia

PH Nguyen, O Fedorchenko, N Rosen, M Koch… - Cancer Cell, 2016 - cell.com
Survival of chronic lymphocytic leukemia (CLL) cells strictly depends on the support of an
appropriate tumor microenvironment. Here, we demonstrate that LYN kinase is essential for …